IMIPRAMINE Safety Questions, IMIPRAMINE Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about IMIPRAMINE. Our extensive database of IMIPRAMINE adverse events and IMIPRAMINE warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about IMIPRAMINE
IMIPRAMINE Safety Reports
Total IMIPRAMINE reports: 16.IMIPRAMINE FDA safety alerts: No.
Reported deaths: 5 Reported hospitalizations: 5.
Take IMIPRAMINE Side Effects Survey or Share Your IMIPRAMINE Story. Read More Here.
Physician from UNITED STATES reported IMIPRAMINE problem on Nov 30, 2006. Female patient, 27 years of age, was treated with IMIPRAMINE. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, completed suicide. IMIPRAMINE dosage: unknown. During the same period patient was treated with AMITRIPTYLINE. Patient died.
IMIPRAMINE problem was reported by a Health Professional from TAIWAN, PROVINCE OF CHINA on Jan 18, 2007. Male patient, 59 years of age, was diagnosed with major depression and was treated with IMIPRAMINE. After drug was administered, patient experienced the following problems/side effects: arteriospasm coronary, atrioventricular block complete, blood cholesterol increased, blood uric acid increased, chest discomfort, circulatory collapse, convulsion, coronary artery stenosis, electrocardiogram st segment depression. IMIPRAMINE dosage: 112 MG/DAY. During the same period patient was treated with LITHIUM CARBONATE. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported IMIPRAMINE problem on Feb 26, 2007. Female patient, weighting 155.0 lb, was diagnosed with anxiety, depression and was treated with IMIPRAMINE. After drug was administered, patient experienced the following problems/side effects: hot flush, nausea, night sweats. IMIPRAMINE dosage: unknown. Patient recovered.
IMIPRAMINE problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 13, 2007. Male patient, 60 years of age, weighting 290.0 lb, was diagnosed with headache and was treated with IMIPRAMINE. After drug was administered, patient experienced the following problems/side effects: benign prostatic hyperplasia, chills, confusional state, depression, irritability, no therapeutic response, suicidal ideation, suicide attempt. IMIPRAMINE dosage: 10 MG NIGHTLY PO. During the same period patient was treated with HYDROCHLOROTHIAZIDE, TYLENOL. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported IMIPRAMINE problem on Mar 15, 2007. Male patient, 60 years of age, weighting 290.0 lb, was diagnosed with headache and was treated with IMIPRAMINE. After drug was administered, patient experienced the following problems/side effects: apathy, benign prostatic hyperplasia, chills, confusional state, depression, dysuria, irritability, suicidal ideation. IMIPRAMINE dosage: 10 MG NIGHTLY PO. During the same period patient was treated with HYDROCHLOROTHIAZIDE, TYLENOL. Patient was hospitalized. Patient recovered.
IMIPRAMINE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 09, 2007. Female patient, 71 years of age, weighting 272.0 lb, was treated with IMIPRAMINE. After drug was administered, patient experienced the following problems/side effects: pruritus. IMIPRAMINE dosage: unknown. Patient recovered.
Consumer or non-health professional from UNITED STATES reported IMIPRAMINE problem on Apr 12, 2007. Female patient was treated with IMIPRAMINE. After drug was administered, patient experienced the following problems/side effects: agitation neonatal, poor sucking reflex, somnolence neonatal. IMIPRAMINE dosage: MATERNAL DOSE: 80 MG/DAY. During the same period patient was treated with CLONAZEPAM, RISPERDAL, ALCOHOL. Patient recovered.
IMIPRAMINE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 02, 2006. Female patient was diagnosed with migraine and was treated with IMIPRAMINE. After drug was administered, patient experienced the following problems/side effects: intracranial aneurysm. IMIPRAMINE dosage: unknown. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported IMIPRAMINE problem on Aug 10, 2006. Female patient, 36 years of age, weighting 250.0 lb, was diagnosed with depression and was treated with IMIPRAMINE. After drug was administered, patient experienced the following problems/side effects: hepatic steatosis. IMIPRAMINE dosage: 200 MG, QHS, ORAL. During the same period patient was treated with SEROQUEL, METFORMIN, LEVOXYL, BUPROPION, GABAPENTIN, TRAZODONE, DIAZEPAM, METHADONE. Patient died on 05/02/2006.
IMIPRAMINE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 15, 2006. Female patient, 36 years of age, weighting 250.0 lb, was diagnosed with depression and was treated with IMIPRAMINE. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, blood urea decreased, carbon dioxide increased, disorientation, dysarthria, electrocardiogram t wave amplitude decreased, hepatic steatosis, pain. IMIPRAMINE dosage: 200 MG, QHS, ORAL. During the same period patient was treated with METHADONE HYDROCHLORIDE, SEROQUEL, METFORMIN, LEVOXYL, BUPROPION, GABAPENTIN, TRAZODONE, DIAZEPAM. Patient died on 05/02/2006.
Consumer or non-health professional from UNITED STATES reported IMIPRAMINE problem on Oct 16, 2006. Female patient, 45 years of age, weighting 160.0 lb, was diagnosed with depression, panic disorder and was treated with IMIPRAMINE. After drug was administered, patient experienced the following problems/side effects: anxiety, dyspnoea, economic problem, heart rate increased, memory impairment, pruritus, respiratory rate decreased, somnolence, stress. IMIPRAMINE dosage: 75 MG 1X A DAY HS PO. Patient recovered.
IMIPRAMINE problem was reported by a Physician from UNITED STATES on Oct 24, 2006. Female patient, 27 years of age, was treated with IMIPRAMINE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, completed suicide, respiratory arrest. IMIPRAMINE dosage: unknown. During the same period patient was treated with AMITRIPTYLINE. Patient died.
Consumer or non-health professional from UNITED STATES reported IMIPRAMINE problem on Oct 30, 2006. Female patient, 27 years of age, was treated with IMIPRAMINE. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, completed suicide. IMIPRAMINE dosage: unknown. During the same period patient was treated with AMITRIPTYLINE. Patient died.
IMIPRAMINE problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 27, 2006. Female patient, 23 years of age, weighting 120.0 lb, was diagnosed with depression and was treated with IMIPRAMINE. After drug was administered, patient experienced the following problems/side effects: asthenia, balance disorder, benign neoplasm, dizziness, feeling abnormal, heart rate abnormal, nervous system disorder, photophobia, visual disturbance. IMIPRAMINE dosage: 25-150 MG. PER DAY DAILY PO. Patient recovered.
Physician from JAPAN reported IMIPRAMINE problem on Dec 19, 2006. Male patient, 57 years of age, was diagnosed with cancer pain and was treated with IMIPRAMINE. After drug was administered, patient experienced the following problems/side effects: hallucination, labile blood pressure, neuroleptic malignant syndrome, rhabdomyolysis. IMIPRAMINE dosage: unknown. During the same period patient was treated with PROCHLORPERAZINE, MORPHINE. Patient recovered.
IMIPRAMINE problem was reported by a Health Professional from TURKEY on July 19, 2007. Female patient, 20 years of age, was diagnosed with overdose and was treated with IMIPRAMINE. After drug was administered, patient experienced the following problems/side effects: glasgow coma scale abnormal, intubation, overdose, therapeutic agent toxicity. IMIPRAMINE dosage: 1000 MG. Patient was hospitalized. Patient recovered.